Fig. 3

Chemical structures (continued): (a) Lomustine, (b) Melphalan, (c) Midostaurin, (d) Mitomycin C, (e) Nilotinib, (f) Olaparib, (g) Olutasidenib, (h) Orgovyx, (i) Plerixafor, (j) Pomalidomide, (k) Pralatrexate, (l) Prednisone, (m) Repotrectinib, (n) Ribociclib, (o) Zanubrutinib.